Pharmacies - NAFTA | Statista Market Forecast

The Pharmacies market in NAFTA is expected to witness significant growth in the coming years.
According to projections, the revenue in this market is estimated to reach US$457.60bn by 2024.
Furthermore, it is anticipated that the market will experience a steady annual growth rate of 3.96% from 2024 to 2029.
This will result in a market volume of US$555.70bn by 2029.
When compared to other countries, United States is expected to generate the highest revenue in the Pharmacies market within NAFTA.
In 2024 alone, United States is projected to generate a revenue of US$387.30bn.
To put these figures into perspective, in 2024, the per person revenue generated in the Pharmacies market is estimated to be US$896.70.
This demonstrates the significant economic impact and importance of the Pharmacies market in NAFTA.
In the NAFTA region, pharmacies in Mexico have seen a surge in demand for over-the-counter medicines due to the affordability and accessibility of these products.

Definition:
Pharmacies are physical or digital places where mainly pharmaceuticals and medical products are sold. Additionally, they also sell other items that are generally found in a pharmacy, such as food supplements, cosmetic products, and other health-related goods. A large proportion of pharmaceuticals are only available on prescription; the rest of the product range of pharmacies is sold over the counter (OTC). Besides selling products, pharmacies also advise customers, inform them about undesirable effects of the products, and detect possible interactions with other medicines.

Structure:
The Pharmacies market consists of two markets: Prescriptions Drugs and OTC Products. The Prescription Drugs market covers all products – mainly pharmaceuticals – that are only available on prescription. The OTC Products market comprises all products that are sold over the counter (OTC), including pharmaceuticals, medical devices, and other items that are generally found in a pharmacy.

Additional information:
The KPIs shown include revenue, revenue growth, average revenue per pharmacy, average revenue per capita, number of pharmacies, pharmacy density, users, and the online sales share for the OTC Products market. Revenues are generated through offline and online spending by (B2C) consumers and include VAT. B2B and B2G sales as well as other pharmaceutical sales through hospitals or retail stores, such as supermarkets, are not included.
For more information on the data displayed, use the info button next to the boxes.

Prescription pharmaceuticals
Prescription medical products
OTC pharmaceuticals
OTC medical products
Pharmacy-usual items

Services such as vaccinations
Sales through hospitals or retail stores

The Pharmacies market in NAFTA is experiencing significant growth and development.

Customer preferences: Customers in the NAFTA region are increasingly seeking convenience and accessibility when it comes to purchasing pharmaceutical products. They value the ability to easily access medications and healthcare products, and prefer to have a wide range of options available to them. Additionally, customers in this region tend to prioritize quality and affordability when choosing a pharmacy.

Trends in the market: One of the key trends in the Pharmacies market in NAFTA is the rise of e-commerce and online pharmacies. With the increasing use of technology and the internet, more customers are turning to online platforms to purchase their medications and healthcare products. This trend is driven by the convenience and accessibility offered by online pharmacies, as well as the ability to compare prices and access a wider range of products. In response to this trend, traditional brick-and-mortar pharmacies are also investing in their online presence to cater to the changing customer preferences. Another trend in the market is the growing demand for personalized healthcare services. Customers are seeking pharmacies that offer personalized advice and recommendations, as well as additional healthcare services such as vaccinations and health screenings. This trend is driven by the increasing focus on preventive healthcare and the desire for a more holistic approach to wellness. Pharmacies that are able to offer these personalized services are likely to gain a competitive advantage in the market.

Local special circumstances: Each country within the NAFTA region has its own unique set of circumstances that impact the Pharmacies market. For example, in the United States, the market is highly competitive and fragmented, with both large chain pharmacies and independent pharmacies coexisting. In Canada, on the other hand, the market is more consolidated, with a few major players dominating the industry. In Mexico, there is a growing trend towards the establishment of pharmacy chains, as well as an increasing focus on generic medications.

Underlying macroeconomic factors: The growth and development of the Pharmacies market in NAFTA can be attributed to several underlying macroeconomic factors. One such factor is the aging population in the region. As the population ages, the demand for healthcare products and services, including medications, is expected to increase. Additionally, rising healthcare costs and the increasing prevalence of chronic diseases are driving the demand for affordable and accessible healthcare solutions, which pharmacies are well-positioned to provide. Furthermore, government policies and regulations play a significant role in shaping the Pharmacies market in NAFTA. For example, in the United States, the implementation of the Affordable Care Act has increased access to healthcare for millions of Americans, leading to a higher demand for pharmacy services. In Canada, government regulations on drug prices and reimbursement policies impact the profitability of pharmacies. In Mexico, government initiatives to expand healthcare coverage and improve access to medications are driving the growth of the market. In conclusion, the Pharmacies market in NAFTA is experiencing growth and development driven by changing customer preferences, such as the demand for convenience and personalized healthcare services. The rise of e-commerce and online pharmacies, as well as the aging population and government policies, are also contributing to the growth of the market. Understanding these trends and special circumstances is crucial for businesses operating in the Pharmacies market in NAFTA to stay competitive and capitalize on the opportunities presented by this evolving market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.